T. Rowe Price Associates’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-189,491
Closed -$6.03M 2965
2023
Q4
$6.03M Sell
189,491
-11,227
-6% -$353K ﹤0.01% 1170
2023
Q3
$7.08M Sell
200,718
-50,380
-20% -$1.92M ﹤0.01% 1125
2023
Q2
$9.54M Hold
251,098
﹤0.01% 1084
2023
Q1
$9.48M Hold
251,098
﹤0.01% 1070
2022
Q4
$10.6M Sell
251,098
-1,100
-0.4% -$45.3K ﹤0.01% 1038
2022
Q3
$8.1M Hold
252,198
﹤0.01% 1101
2022
Q2
$8.19M Sell
252,198
-1,235,837
-83% -$40M ﹤0.01% 1350
2022
Q1
$53.8M Sell
1,488,035
-214,996
-13% -$7.38M 0.01% 945
2021
Q4
$67.4M Sell
1,703,031
-106,547
-6% -$4.44M 0.01% 895
2021
Q3
$79.1M Sell
1,809,578
-182,863
-9% -$8.21M 0.01% 844
2021
Q2
$81.4M Buy
1,992,441
+39,357
+2% +$1.52M 0.01% 865
2021
Q1
$64.1M Buy
1,953,084
+1,536,846
+369% +$57.8M 0.01% 913
2020
Q4
$16.9M Buy
416,238
+263,788
+173% +$9.86M ﹤0.01% 1257
2020
Q3
$5.58M Buy
+152,450
New +$5.51M ﹤0.01% 1391
2019
Q4
Sell
-21,613
Closed -$438K 2538
2019
Q3
$438K Buy
+21,613
New +$426K ﹤0.01% 2147

Other funds holding GMAB